seffalair spiromax
teva b.v. - fluticasone propionate, salmeterol xinafoate - astma - medicin for obstruktiv sygdomme, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.
salmeterol/fluticasonpropionat "nordic prime" 25+250 mikrog/dosis inhalationsspray, suspension
nordic prime aps - fluticasonpropionat, salmeterolxinafoat - inhalationsspray, suspension - 25+250 mikrog/dosis
anoro ellipta (previously anoro)
glaxosmithkline (ireland) limited - umeclidinium bromid, vilanterol trifenatate - pulmonal sygdom, kronisk obstruktiv - medicin for obstruktiv sygdomme, - anoro ellipta er anført som vedligeholdelse bronkodilaterende behandling til at lindre symptomer i voksne patienter med kronisk obstruktiv lungesygdom (kol).
laventair ellipta (previously laventair)
glaxosmithkline (ireland) limited - umeclidinium bromid, vilanterol - pulmonal sygdom, kronisk obstruktiv - medicin for obstruktiv sygdomme, - laventair ellipta er anført som vedligeholdelse bronkodilaterende behandling til at lindre symptomer i voksne patienter med kronisk obstruktiv lungesygdom (kol).
oxis turbohaler 4,5 mikrogram/dosis inhalationspulver
orifarm a/s - formoterolfumarat dihydrat - inhalationspulver - 4,5 mikrogram/dosis
oxis turbohaler 9 mikrogram/dosis inhalationspulver
orifarm a/s - formoterolfumarat dihydrat - inhalationspulver - 9 mikrogram/dosis
symbicort forte turbohaler 9+320 mikrog./dosis inhalationspulver
orifarm a/s - budesonid, formoterolfumarat dihydrat - inhalationspulver - 9+320 mikrog./dosis